The current issue of JAMA Dermatology (2024)

Adjuvant Immunotherapy in Stage II Melanoma—Further Risk Stratification is Needed

HannahRashdan,BS; Adewole S.Adamson,MD, MPP; Yevgeniy R.sem*nov,MD, MA

JAMA Dermatol. 2024;160(4):385-386. doi:10.1001/jamadermatol.2024.0045

This Viewpoint reviews the evidence for immune checkpoint inhibitor use in the adjuvant setting, discusses the individual and societal risks, benefits, and costs associated with immune checkpoint inhibitors, and highlights the need for more targeted patient selection approaches.

Matching Drug Prices to Their Clinical Benefit—The Final Frontier?

Edward C. F.Wilson,PhD; Zenas Z. N.Yiu,PhD

JAMA Dermatol. 2024;160(4):387-388. doi:10.1001/jamadermatol.2023.6231

Improving Outcomes in Chronic Graft-vs-Host Disease

Sandra A.Mitchell,PhD, CRNP; Edward W.Cowen,MD, MHSc

JAMA Dermatol. 2024;160(4):388-391. doi:10.1001/jamadermatol.2023.6276

Evolving Trends in Immunohistochemistry Use in Dermatopathology

AlexandraFlamm,MD

JAMA Dermatol. 2024;160(4):391-392. doi:10.1001/jamadermatol.2023.6416

Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease

EmilyBaumrin,MD, MSCE; Daniel B.Shin,PhD; NanditaMitra,PhD; et al.

JAMA Dermatol. 2024;160(4):393-401. doi:10.1001/jamadermatol.2023.6277

This cohort study examines the association of chronic graft-vs-host disease subtype with patient-reported outcomes and evaluates whether these measures can identify patients at higher risk for death.

Incidence and Factors Associated With Second Primary Invasive Melanoma in Norway

RezaGhiasvand,PhD; Adele C.Green,MBBS, PhD; Marit B.Veierød,PhD; et al.

open access

JAMA Dermatol. 2024;160(4):402-408. doi:10.1001/jamadermatol.2023.6251

This cohort study assesses the incidence rate of second primary invasive melanoma at least 30 days after the first based on data from deidentified records of all invasive melanomas diagnosed in 2008 to 2020, obtained from the Cancer Registry of Norway.

Use of Efficiency Frontiers to Align Prices and Clinical Benefits of Biologic Therapies for Plaque Psoriasis

Alexander C.Egilman,BA; Aaron S.Kesselheim,MD, JD, MPH; JerryAvorn,MD; et al.

JAMA Dermatol. 2024;160(4):409-416. doi:10.1001/jamadermatol.2023.6236

This economic evaluation assesses how the efficiency frontier approach could align prices and clinical benefits of biologic medications for plaque psoriasis and estimates price reductions in the US vs 4 peer countries.

Anatomic Subtype Differences in Extramammary Paget Disease: A Meta-Analysis

NourKibbi,MD; Joshua L.Owen,MD, PhD; BrandonWorley,MD, MSc; et al.

JAMA Dermatol. 2024;160(4):417-424. doi:10.1001/jamadermatol.2024.0001

This meta-analysis examines demographic and tumor characteristics and treatment approaches for different extramammary Paget disease subtypes and presents recommendations for diagnosis and treatment.

Clinical, Histologic, and Transcriptomic Evaluation of Sequential Fat Grafting for Morphea: A Nonrandomized Controlled Trial

JuziLiu,MD; JingWang,MD, PhD; QianZhang,MD; et al.

has multimedia

JAMA Dermatol. 2024;160(4):425-433. doi:10.1001/jamadermatol.2023.5908

This nonrandomized trial examines the antisclerotic and regenerative effects of sequential fat grafting with fresh fat and cryopreserved stromal vascular fraction gel for morphea.

Immunohistochemistry for Diagnosing Melanoma in Older Adults

KenechukwuOjukwu,MD, MPP; Megan M.Eguchi,MPH; Adewole S.Adamson,MD, MPP; et al.

JAMA Dermatol. 2024;160(4):434-440. doi:10.1001/jamadermatol.2023.6417

This retrospective cross-sectional study illustrates national-level trends in immunohistochemistry staining for the diagnosis of melanoma in older adult patients enrolled in Medicare.

Identifying Core Outcome Domains in Chronic Skin Disease Using the Best-Worst Scaling Method

AliShields,BS; Frances K.Barg,PhD; Wendy SmithBegolka,MBS; et al.

JAMA Dermatol. 2024;160(4):441-446. doi:10.1001/jamadermatol.2023.6245

This cross-sectional study examines which Patient-Reported Outcomes Measurement Information System domains are most meaningful to those with chronic skin disease.

Symptoms of Cognitive Impairment Among Children With Atopic Dermatitis

Emily Z.Ma,BA; Hannah R.Chang,BA; SarahRadtke,PhD; et al.

has audio

JAMA Dermatol. 2024;160(4):447-452. doi:10.1001/jamadermatol.2024.0015

This cross-sectional study examines whether atopic dermatitis is associated with symptoms of learning or memory difficulties in US children.

• Audio: Symptoms of Cognitive Impairment Among Children With Atopic Dermatitis

Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients

YaelRenert-Yuval,MD, MSc; KhaledEzzedine,MD, PhD; PearlGrimes,MD; et al.

has active quiz

JAMA Dermatol. 2024;160(4):453-461. doi:10.1001/jamadermatol.2024.0021

This consensus statement reports on the development of expert recommendations for treating vitiligo in pediatric, adolescent, and young adult patients in the US.

Favre-Racouchot Syndrome

ZhendongWei,MD; FanWang,MM; SongZheng,MD

has active quiz

JAMA Dermatol. 2024;160(4):462-463. doi:10.1001/jamadermatol.2023.5768

This case report describes multiple solitary open black comedones located bilaterally on the malar cheeks and temples as well as yellowish, smooth-surfaced papulonodular lesions in close association with the comedones.

Mal de Meleda

Pei-YunHo,MD; Yi-TszLin,MD

has active quiz

JAMA Dermatol. 2024;160(4):464-465. doi:10.1001/jamadermatol.2024.0117

This case report describes diffuse waxy palmoplantar hyperkeratosis in a symmetrically well-demarcated “gloves and socks” distribution with nail dystrophy.

Persistent Hyperkeratotic Plaques on a Man’s Genitogluteal Area

QianZhang,MM; Cheng-ChengLiu,MM; Jiu-HongLi,MD, PhD

has active quiz

JAMA Dermatol. 2024;160(4):466-467. doi:10.1001/jamadermatol.2023.4624

A man in his 40s presented with a 10-year history of pruritic lesions on the scrotum and buttock. What is your diagnosis?

Annular Erythematous Eruption in a Pediatric Patient

SamarSheriff,MD, MBA; SoonBahrami,MD; Courtney R.Schadt,MD

has active quiz

JAMA Dermatol. 2024;160(4):468-469. doi:10.1001/jamadermatol.2023.4984

An 11-year-old girl presented in autumn with an asymptomatic rash on her arms, face, and legs of a 3-week duration. What is your diagnosis?

Consent and Identifiability for Patient Images in Research, Education, and Image-Based Artificial Intelligence

TrinaSalvador,BS; LillyGu,BS; Jennifer L.Hay,PhD; et al.

JAMA Dermatol. 2024;160(4):470-472. doi:10.1001/jamadermatol.2024.0084

This survey study reports the perspectives and preferences of US adults regarding use of photographs of their skin in medical research, education, and development of image-based artificial intelligence (AI).

Deep Vein Thrombosis and Healing Outcomes in Patients With Pyoderma Gangrenosum

HannahZhao,BA; Sidharth K.Sengupta,BS; Jonathan M.Sisley,BS; et al.

JAMA Dermatol. 2024;160(4):472-474. doi:10.1001/jamadermatol.2023.6066

This single-center prospective case-control study assessed the association between deep vein thrombosis and healing outcomes in patients with pyoderma gangrenosum.

Macrocheilia as an Atypical Clinical Presentation of Capillary Malformation–Arteriovenous Malformation Type 2

RogerRovira-López,MD; Luis A.Pérez-Jurado,MD, PhD; Ramon M.Pujol,MD, PhD

JAMA Dermatol. 2024;160(4):474-476. doi:10.1001/jamadermatol.2023.5805

This case report describes a 53-year-old man with multiple erythematous macules and papules diffusely distributed on the frontal area, cheeks, eyelids, nose, and supralabial skin.

Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau

YoucongWang,MD; LiZhang,PhD; JieZheng,MD, PhD; et al.

JAMA Dermatol. 2024;160(4):476-477. doi:10.1001/jamadermatol.2023.6349

This case report summarizes the treatment of acrodermatitis continua of Hallopeau with spesolimab in a 9-year-old girl.

Cooling Research Fever in Dermatology—The Role of Community Service

Angela L.Zhang,BA; Victoria S.Humphrey,MD; John C.Trinidad,MD, MPH

JAMA Dermatol. 2024;160(4):477-478. doi:10.1001/jamadermatol.2023.6096

Cooling Research Fever in Dermatology—The Role of Community Service—Reply

JocelynGandelman,MD; ErinMathes,MD; DanielButler,MD

JAMA Dermatol. 2024;160(4):478. doi:10.1001/jamadermatol.2023.6092

Error in Corresponding Author’s Address

free access

JAMA Dermatol. 2024;160(4):478. doi:10.1001/jamadermatol.2022.2066

JAMA Dermatology

free access

JAMA Dermatol. 2024;160(4):383. doi:10.1001/jamadermatol.2023.3980